Korean Biotechs Battle For Funding and Attention Underneath Chinese Shadow
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Korean biotechs are producing siginificant R&D output, but there is a disconnect between local companies' scientific and financial success, and the country needs to utilize new models to build a viable biotech industry, according to panelists at Bio Korea 2010